APP and Alzheimer disease: TgF344-AD transgenic rats overexpress mutated human PSEN1 (PSEN1ΔE9) and human APP with the Swedish mutation (APPSWE) and were developed with the intention of creating an improved animal model of AD that recapitulates a broader spectrum of neuropathological features seen in the human AD brain (Cohen et al., 2013).